Cargando…
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies
BACKGROUND: Patient-derived tumor xenograft models have been established and increasingly used for preclinical studies of targeted therapies in recent years. However, patient-derived non-small cell lung cancer (NSCLC) xenograft mouse models are relatively few in number and are limited in their degre...
Autores principales: | Zhang, Xu-chao, Zhang, Jingchuan, Li, Ming, Huang, Xiao-sui, Yang, Xue-ning, Zhong, Wen-zhao, Xie, Liang, Zhang, Lin, Zhou, Minhua, Gavine, Paul, Su, Xinying, Zheng, Li, Zhu, Guanshan, Zhan, Ping, Ji, Qunsheng, Wu, Yi-long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716998/ https://www.ncbi.nlm.nih.gov/pubmed/23842453 http://dx.doi.org/10.1186/1479-5876-11-168 |
Ejemplares similares
-
Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models
por: Wu, Xianhua, et al.
Publicado: (2012) -
Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity
por: Zhang, Tianwei, et al.
Publicado: (2015) -
Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma
por: Gavine, Paul R., et al.
Publicado: (2015) -
Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation
por: Cavalloni, Giuliana, et al.
Publicado: (2016) -
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere
por: Li, Jing, et al.
Publicado: (2013)